Cannabinoids and Efficacy
Accessing new drugs for trials can be challenging, as highlighted by ongoing research into a non-psychoactive cannabinoid. While initial studies show potential for treating conditions like PTSD and social anxiety, the subjective experiences of elevated anandamide levels differ significantly from those of THC. This distinction raises intriguing questions about the therapeutic applications of cannabinoids without the common psychoactive effects.In this clip
From this podcast
Huberman Lab
Dr. Matthew Hill: How Cannabis Impacts Health & the Potential Risks
Related Questions